Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Takara Bio USA, Inc.

News headline image
Takara Bio USA, Inc. Announces the Retirement of Carol Lou, Appoints Andrew Farmer as President and CEO
From Takara Bio USA, Inc.
Via Business Wire
News headline image
Takara Bio USA, Inc. to Showcase Instrument-Free Approach to Spatial Biology at Human Cell Atlas 2026 Meeting
From Takara Bio USA, Inc.
Via Business Wire
News headline image
Takara Bio USA, Inc. Validates New Class of Spatial Technology with Benchmark Study for Cancer Research
From Takara Bio USA, Inc.
Via Business Wire
News headline image
Takara Bio USA, Inc. Launches Certified Service Provider Program to Advance Research Using NGS and Single-Cell Technologies
From Takara Bio USA, Inc.
Via Business Wire
News headline image
Takara Bio USA and Hamilton Company Partner to Automate NGS Library Preparation
From Takara Bio USA, Inc.
Via Business Wire
News headline image
Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026
From Takara Bio USA, Inc.
Via Business Wire
News headline image
Takara Bio USA, Inc. Brings New Class of Spatial Technology to Archival Samples with FFPE-Ready Kit
From Takara Bio USA, Inc.
Via Business Wire
News headline image
Takara Bio Launches High-Throughput, Cost-Effective qPCR System to Advance Clinical Research
From Takara Bio USA, Inc.
Via Business Wire
News headline image
Takara Bio Launches Large-Scale, Flexible qPCR System to Advance Broad Surveillance of Antimicrobial Resistance
From Takara Bio USA, Inc.
Via Business Wire
News headline image
Takara Bio Launches First Commercial Dissolvable Microfluidic Lentiviral Transduction Enhancer
From Takara Bio USA, Inc.
Via Business Wire
News headline image
Takara Bio transforms single-cell landscape with new large-scale NGS profiling system for oncology biomarker discovery
From Takara Bio USA, Inc.
Via Business Wire
News headline image
Takara Bio’s First-to-Market Large-Scale Single-Cell NGS Profiling Technologies Poised to Revolutionize Biomarker Discovery
From Takara Bio USA, Inc.
Via Business Wire
News headline image
Takara Bio USA Wins EU Opposition Hearing, Revoking Jumpcode Genomics’ NGS Library Enrichment Patent
From Takara Bio USA, Inc.
Via Business Wire
News headline image
Takara Bio USA, Inc. and BioExcel Diagnostics Partner for Development of Wide-Coverage Infectious Disease Detection Panels
From Takara Bio USA, Inc.
Via Business Wire
News headline image
Takara Bio USA Wins EU Opposition Hearing on its Foundational NGS Library Enrichment Patent
From Takara Bio USA, Inc.
Via Business Wire
News headline image
Takara Bio USA, Inc. Launches Automated, Full-Length Single-Cell RNA-seq Solution for Enhanced Biomarker Discovery
From Takara Bio USA, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.